Gershan Davis

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 344 citations · Full text

Heart Failure, Intravenous Ferric Derisomaltose, Iron Metabolism +3

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 276 citations · Full text

Myocardial Infarction as a Presentation of Clinical In-Stent Restenosis

Atasu Nayak, Akio Kawamura, Richard W. Nesto et al. · Circulation Journal · 2006 · 87 citations · Full text

Changes of fibrinolysis and factor VIII coagulant, antigen, and ristocetin cofactor in diabetes mellitus and atherosclerosis

Murray M. Bern, M.P. Cassani, Jay D. Horton et al. · Thrombosis Research · 1980 · 47 citations

Inflammation, Metabolic Syndrome, Vascular Disease +14

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Giulio Francesco Romiti, Bernadette Corica, Marco Proietti et al. · EClinicalMedicine · 2023 · 38 citations · Full text